He introduced a stock-trading ban on May 6. Nine days later he sold $130K in Medicaid insurers.

Robert P. Bresnahan Jr. represents Pennsylvania's 8th congressional district, which covers Scranton, Wilkes-Barre, Luzerne and Lackawanna counties, and the blue-collar economy of Northeastern Pennsylvania. He is one of the youngest sitting members of Congress, born April 22, 1990, in Kingston, Pennsylvania.

His professional background is in family business. At age 19 he became CFO of Kuharchik Construction, his grandfather's electrical contracting firm based in Exeter, PA. He became CEO in 2013, grew the company to over 150 employees, and expanded operations into power distribution and intelligent transportation systems. He also owns RPB Ventures, a real estate development company focused on the Main Street of Pittston, PA. Public estimates of his net worth range between roughly $34 million (Spotlight PA, 2026) and $48 million (Philadelphia Inquirer, 2025). He had no prior elected office before 2025.

In 2024 he ran for the open Republican nomination in PA-08, was endorsed by Donald Trump in April, and defeated three-term incumbent Democratic Rep. Matt Cartwright on November 5, 2024, by a margin of roughly 1.6 points (50.8 percent). The race was one of the most expensive House contests of the cycle. He took office in January 2025. In August 2025 he married Chelsea Strub, a former WNEP-TV news anchor.

Bresnahan ran on economic populism, blue-collar credibility, and explicit promises to "drain the swamp," including ending congressional stock trading. The first four months of his tenure are now the test case for those promises.

Bresnahan's three committee assignments in the 119th Congress are Transportation and Infrastructure (where he is vice chair of the Subcommittee on Highways and Transit), House Agriculture (subcommittees on Conservation, Research, and Biotechnology; and Commodity Markets, Digital Assets, and Rural Development), and Small Business. These are sensible committees for a freshman from a Pennsylvania district built on infrastructure, agriculture, and small enterprise.

None of these committees has direct jurisdiction over Medicare, Medicaid, the Affordable Care Act, or any private insurer. The committees that do (Senate Finance, House Ways and Means Health Subcommittee, House Energy and Commerce Health Subcommittee, Senate HELP) all have different members. We map the full set of insurer-oversight committees in Congress and health insurance stock trades.

That distinction matters for the editorial framing of this profile. Bresnahan did not vote on Medicaid as a committee participant who had spent months in markup hearings on the program. He voted on it on the House floor, as a rank-and-file member with whatever public and political knowledge any member of the majority would have on the day of the vote. The case against the timing of the trades does not rest on committee leverage. It rests on the fact that he introduced a bill banning the exact behavior he then engaged in, sixteen days before the vote that produced the move.

This is the inverse of the leverage frame in profiles like Pelosi (committee chair influencing tech), Tuberville (Armed Services member trading defense), or Khanna (Select Committee on the CCP shaping chip exports while household trades NVIDIA). The Bresnahan case is about the floor vote and the public-information timing around it.

On May 6, 2025, four months into his first term, Bresnahan introduced the Transparency in Representation through Uniform Stock Trading Ban Act, designated H.R. 3182. The bill would prohibit members of Congress and their spouses from buying or selling individual stocks while in office. Existing holdings would be grandfathered. Qualified blind trusts would be exempt. If enacted, the ban would take effect at the start of the 120th Congress in January 2027.

The same press release announced that Bresnahan would put his existing portfolio into a blind trust. Reform advocates noted the gesture, including the inclusion of a spouse clause that closes one of the loopholes covered in our editorial on the spouse loophole at the heart of every active ban bill.

The blind trust did not come together. On July 17, 2025, his legal team filed a letter to the House Ethics Committee acknowledging that the standard qualified-blind-trust framework requires an independent trustee with no relationship to the member, which conflicted with his desire to retain his existing financial advisors. The letter substituted two interim guardrails: no investments in firms based in or owned by U.S. adversaries, including foreign-heavy funds; and no short-selling of U.S. companies. Beyond those rules, the letter stated, "third-party advisors, and not Rep. Bresnahan, have complete discretion." Bresnahan publicly called the blind-trust process "excruciating." His full ban bill, H.R. 3182, has not advanced.

On December 10, 2025, after roughly six months of news cycles around the Medicaid trades, he signed Discharge Petition No. 11 to force a House floor vote on Rep. Tim Burchett's competing End Congressional Stock Trading Act (H.R. 1908). He was the 37th member of the House to sign. Discharge petitions require 218 signatures to bypass leadership and force a vote. As of writing, the petition has not reached that threshold. The reform vehicles he has supported are covered in our scorecard at the congressional stock trading ban bills compared.

The Medicaid trades are not isolated. Public disclosure data aggregators show Bresnahan's account filed more than 650 disclosed transactions across more than 300 issuers in 2025 alone, with total disclosed volume above $8 million. By the August 2025 cycle his trading pace was approximately five times that of Sen. Dave McCormick, the next-most-active member of the Pennsylvania congressional delegation. One disclosed day in May 2025 recorded 171 separate trades.

The sector breakdown skews technology (190 trades), healthcare (103), industrials (74), and consumer discretionary (54). Top traded tickers by count: Berkshire Hathaway (17), NVIDIA (14), Intel (10), Tesla (10). No documented options activity is in the reviewed PTRs.

Two non-Medicaid trades have drawn similar scrutiny on their own merits. On April 8, 2025, the account sold Tractor Supply (TSCO) during the China-tariff-week selloff, the same week TSCO fell roughly 14 percent across sessions. On February 25, 2025, the account purchased Lockheed Martin (LMT) in the $1,001 to $15,000 bracket. Roughly two weeks later, Bresnahan's campaign received a $1,000 PAC donation from Lockheed Martin. On June 13, 2025, Israeli strikes on Iran (Operation Rising Lion) sent Lockheed and other defense contractors to all-time highs. The full cluster of congressional defense trades around the Iran strikes is mapped in our editorial on congressional defense stock trades; the April 2025 tariff window is mapped in congress tariff trades 2025.

The pattern stops abruptly. From January 2026 through the most recent Spotlight PA reporting in May 2026, the account has disclosed zero individual stock trades. The only purchases on file are municipal and state bonds: Pennsylvania Turnpike Commission and Parkland School District bonds, each in the $50,000 to $100,000 bracket, in March 2026. The cold-turkey freeze is itself a story. NOTUS published a piece in May 2026 framing it as the only meaningful behavioral consequence of the eleven months of news cycles.

In April 2026, the Cook Political Report moved PA-08 from Lean Republican to Toss Up, citing the stock-trading scrutiny as a primary driver. Bresnahan's Democratic challenger is Scranton Mayor Paige Cognetti. In Q1 2026 reports, Cognetti out-raised the incumbent: $1.46 million to $1.2 million. PA-08 is now one of three Pennsylvania toss-up House seats for the 2026 cycle, alongside Mackenzie in PA-07 and Perry in PA-10.

On March 10, 2026, former Republican Rep. James Greenwood (who represented PA-08 from 1993 to 2005) publicly called for Bresnahan's resignation, citing the contradiction between Bresnahan's April 2025 statement that he met with his advisor about positions and his later claim of zero involvement. The Bresnahan campaign called Greenwood a "washed-up political has-been."

The accountability question is now bilateral. Cook says the seat is in play because of the trading. The 2026 trading freeze suggests Bresnahan agrees the optics had become unsustainable. Whether the freeze is a permanent change, an electoral defensive posture, or both will become clearer once the November 2026 results are in. For broader context on how reformer claims and household trading interact in the modern Congress, see the spouse loophole, documented insider-trading cases, and the sector explainer that grew out of this one: congress and health insurance stock trades.